


AstraZeneca Phase III Trial Earns Success Against Lung Cancer
By Madeline May |
Two crucial oncology medications for AstraZeneca have returned with clinical trial wins in early-stage non-small cell lung cancer (NSCLC).
Two crucial oncology medications for AstraZeneca have returned with clinical trial wins in early-stage non-small cell lung cancer (NSCLC).
By Madeline May |
By Kristina Johnson |
By Megan O'Leary |